Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Doramapimod | IC50 | 300.0 [1], 1968.0 [2] | |
| 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 87600000.0 [1] | |
| Tofacitinib | IC50 | 10000.0 [1] | |
| Cyclohexanol, 4-(4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl)-, trans- | IC50 | 100000.0 [1] | |
| Benzamide, N-[4-[2-ethyl-4-(3-methylphenyl)-5-thiazolyl]-2-pyridinyl]- | IC50 | 10000.0 [1] | |
MLA | "Quest Database™ MAP kinase p38 delta Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 24 Dec. 2025, https://www.aatbio.com/data-sets/map-kinase-p38-delta-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 24). Quest Database™ MAP kinase p38 delta Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/map-kinase-p38-delta-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |